|
C22ORF30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.988100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.53710000000618E-05 |
| Normal-vs-Stage2 |
2.416400E-01 |
| Normal-vs-Stage3 |
5.581000E-03 |
| Normal-vs-Stage4 |
1.032770E-04 |
| Stage1-vs-Stage2 |
2.576000E-01 |
| Stage1-vs-Stage3 |
9.349000E-01 |
| Stage1-vs-Stage4 |
2.344800E-01 |
| Stage2-vs-Stage3 |
3.940000E-01 |
| Stage2-vs-Stage4 |
1.144600E-01 |
| Stage3-vs-Stage4 |
2.293200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.241060E-04 |
| Normal-vs-AfricanAmerican |
4.644200E-03 |
| Normal-vs-Asian |
2.024600E-03 |
| Caucasian-vs-AfricanAmerican |
8.340400E-01 |
| Caucasian-vs-Asian |
4.386200E-01 |
| AfricanAmerican-vs-Asian |
3.974000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99101999999174E-05 |
| Normal-vs-Female |
3.243000E-01 |
| Male-vs-Female |
2.374400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.988500E-04 |
| Normal-vs-Extreme_Weight |
1.04879999995866E-06 |
| Normal-vs-Obese |
3.743700E-02 |
| Normal-vs-Extreme_Obese |
1.567730E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.607400E-01 |
| Normal_Weight-vs-Obese |
1.061030E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.725000E-01 |
| Extreme_Weight-vs-Obese |
1.561900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.691800E-01 |
| Obese-vs-Extreme_Obese |
4.943200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.927820E-01 |
| Normal-vs-Age(41-60Yrs) |
1.671840E-02 |
| Normal-vs-Age(61-80Yrs) |
3.74459999999965E-05 |
| Normal-vs-Age(81-100Yrs) |
4.49990000039868E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.743600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.161800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.156300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.595800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.798400E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.080400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.246200E-04 |
| Normal-VS-Type2 PRCC |
1.06300000002335E-06 |
| Normal-VS-KIRP CIMP |
2.019000E-01 |
| Normal-VS-Unclassified PRCC |
1.847810E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.897900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.172000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.930200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.730000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.494500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.419000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.54940000000248E-05 |
| Normal-vs-N1 |
1.454610E-01 |
| Normal-vs-N2 |
6.341500E-02 |
| N0-vs-N1 |
2.688200E-01 |
| N0-vs-N2 |
8.093400E-01 |
| N1-vs-N2 |
7.441800E-01 |
|
|
